Trial Profile
Randomized Controlled Trial of Lorcaserin for Cannabis Use Disorder
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- 12 Jan 2021 Status changed from suspended to discontinued.
- 17 Apr 2020 Status changed from recruiting to suspended.
- 05 Mar 2019 Status changed from not yet recruiting to recruiting.